Paritaprevir, CAS [[1216941-48-8]]

Produktübersicht

• Artikelname: Paritaprevir, CAS [[1216941-48-8]]
• Artikelnummer: BYT-ORB1305953
• Hersteller Artikelnummer: orb1305953
• Alternativnummer: BYT-ORB1305953-5, BYT-ORB1305953-10, BYT-ORB1305953-1, BYT-ORB1305953-25
• Hersteller: Biorbyt
• Kategorie: Biochemikalien
• Alternative Synonym: Ritonavir, SARS coronavirus, SARS-CoV 3CLPpro, SARS-CoV, Veruprevir, 1221573-85-8, ABT450, ABT-450, ABT 450, CYP450, Inhibitor, HCV 1a, HCV 1b, HCV genotype 1a, HCV genotype 1b, HCV, HCVProtease, HCV Protease, HCV NS3/4A, Hepatitis C virus, inhibit, NS3/4A, Paritaprevir, orally active

Produktbeschreibung

Paritaprevir (ABT450) is a potent small molecule inhibitor targeting the HCV NS3/4A serine protease. It demonstrates high antiviral activity with EC50 values of 1 nM against HCV genotype 1a and 0.21 nM against genotype 1b. This compound is a key research tool for studying HCV replication and antiviral mechanisms in biochemical and cellular assays.

Produkteigenschaften

• Molekulargewicht: 765.88
• Reinheit: 99.72% (May vary between batches)
• CAS Nummer: [1216941-48-8]
• Formel: C40H43N7O7S
• Target-Kategorie: SARS-CoV,HCV Protease

Anwendungsbeschreibung

• Anwendungsbeschreibung: Solubility: DMSO:80 mg/mL (104.46 mM),10% DMSO+40% PEG300+5% Tween 80+45% Saline:3.3 mg/mL (4.31 mM)